ZA997265B - Leptospira vaccine antigens for the prevention of leptospirosis. - Google Patents

Leptospira vaccine antigens for the prevention of leptospirosis.

Info

Publication number
ZA997265B
ZA997265B ZA9907265A ZA997265A ZA997265B ZA 997265 B ZA997265 B ZA 997265B ZA 9907265 A ZA9907265 A ZA 9907265A ZA 997265 A ZA997265 A ZA 997265A ZA 997265 B ZA997265 B ZA 997265B
Authority
ZA
South Africa
Prior art keywords
leptospirosis
prevention
vaccine antigens
leptospira vaccine
leptospira
Prior art date
Application number
ZA9907265A
Other languages
English (en)
Inventor
Don Alan Dearwester
Eric Andrew Utt
Michael Stephen Willy
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA997265B publication Critical patent/ZA997265B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA9907265A 1998-12-22 1999-11-23 Leptospira vaccine antigens for the prevention of leptospirosis. ZA997265B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11328898P 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ZA997265B true ZA997265B (en) 2001-05-23

Family

ID=22348590

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907265A ZA997265B (en) 1998-12-22 1999-11-23 Leptospira vaccine antigens for the prevention of leptospirosis.

Country Status (10)

Country Link
US (2) US6482924B1 (fr)
EP (1) EP1020516A3 (fr)
JP (4) JP2000189179A (fr)
CN (1) CN1257872A (fr)
AR (1) AR020852A1 (fr)
AU (1) AU6527299A (fr)
BR (1) BR9905780A (fr)
CA (1) CA2290219A1 (fr)
NZ (1) NZ501213A (fr)
ZA (1) ZA997265B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
MX345704B (es) 2011-06-10 2017-02-10 Novartis Tiergesundheit Ag Vacuna bovinas y métodos.
US10143735B2 (en) * 2014-03-12 2018-12-04 Yale University Compositions and methods of preparing Leptospira
CN105628773B (zh) * 2014-11-05 2019-07-16 中国食品药品检定研究院 一种用于细菌性疫苗菌种的质量控制的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
ATE224202T1 (de) * 1993-03-31 2002-10-15 Univ California Cloniertes protein der äusseren membran von leptospira
US5643754A (en) * 1994-05-25 1997-07-01 The Regents Of The University Of California Nucleic acids encoding a leptospira outer membrane protein

Also Published As

Publication number Publication date
CA2290219A1 (fr) 2000-06-22
JP2001190285A (ja) 2001-07-17
US6800734B2 (en) 2004-10-05
JP2001190284A (ja) 2001-07-17
AU6527299A (en) 2000-07-13
US20040043391A1 (en) 2004-03-04
AR020852A1 (es) 2002-05-29
EP1020516A2 (fr) 2000-07-19
EP1020516A3 (fr) 2000-10-11
BR9905780A (pt) 2001-04-24
CN1257872A (zh) 2000-06-28
JP2000189179A (ja) 2000-07-11
JP2001204479A (ja) 2001-07-31
NZ501213A (en) 2001-09-28
US6482924B1 (en) 2002-11-19

Similar Documents

Publication Publication Date Title
HK1043731A1 (en) Vaccine against antigens from bacteriae
HUS1300050I1 (hu) Adjuvánsrendszerek és vakcinák
AU2002336760A8 (en) Mutable vaccines
HUP0202885A3 (en) Vaccines
GB9620795D0 (en) Vaccines
AP2002002424A0 (en) Vaccine
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
HUP0105392A3 (en) Enhanced vaccines
HUP9701586A3 (en) Improved inactivated vaccines
IL130917A (en) Universal t-cell epitopes for anti-malarial vaccines
GB9901254D0 (en) Vaccines
GB9822714D0 (en) Vaccines
EP1032583A4 (fr) Immunisation active contre les antigenes associes a l'angiogenese
ZA997265B (en) Leptospira vaccine antigens for the prevention of leptospirosis.
HUP9903398A3 (en) Coccidiosis vaccines
GB9823835D0 (en) Component for vaccine
EP1210364A4 (fr) Antigenes de vaccin provenant de moraxella
GB9930591D0 (en) Component for vaccine
GB9915419D0 (en) Antigens
AP2001002076A0 (en) Hiv vaccine
IL143100A0 (en) Contraceptive antibody vaccines
GB9930585D0 (en) Component for vaccine
GB0109114D0 (en) Stimulation of the immune system
ZA99872B (en) Vaccine.
IT243650Y1 (it) Apparecchiatura ad alambicco per la preparazione di bevande perinfusione